NZ517565A - Direct aspiration-reaction and injection device and methods of use - Google Patents
Direct aspiration-reaction and injection device and methods of useInfo
- Publication number
- NZ517565A NZ517565A NZ517565A NZ51756500A NZ517565A NZ 517565 A NZ517565 A NZ 517565A NZ 517565 A NZ517565 A NZ 517565A NZ 51756500 A NZ51756500 A NZ 51756500A NZ 517565 A NZ517565 A NZ 517565A
- Authority
- NZ
- New Zealand
- Prior art keywords
- chamber
- elongate member
- reagent composition
- sample
- open end
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 86
- 238000006243 chemical reaction Methods 0.000 title claims description 52
- 238000002347 injection Methods 0.000 title description 5
- 239000007924 injection Substances 0.000 title description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 170
- 239000000203 mixture Substances 0.000 claims abstract description 147
- 238000007789 sealing Methods 0.000 claims abstract description 20
- 230000008859 change Effects 0.000 claims abstract description 10
- 239000011541 reaction mixture Substances 0.000 claims description 53
- 150000007523 nucleic acids Chemical class 0.000 claims description 46
- 230000003321 amplification Effects 0.000 claims description 44
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 44
- 108020004707 nucleic acids Proteins 0.000 claims description 44
- 102000039446 nucleic acids Human genes 0.000 claims description 44
- 230000005670 electromagnetic radiation Effects 0.000 claims description 41
- 238000002844 melting Methods 0.000 claims description 41
- 230000008018 melting Effects 0.000 claims description 41
- 210000004027 cell Anatomy 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 17
- 210000000265 leukocyte Anatomy 0.000 claims description 16
- 239000002981 blocking agent Substances 0.000 claims description 14
- 239000000155 melt Substances 0.000 claims description 13
- 239000012620 biological material Substances 0.000 claims description 12
- 238000012986 modification Methods 0.000 claims description 12
- 230000006037 cell lysis Effects 0.000 claims description 11
- 239000011521 glass Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 229920003023 plastic Polymers 0.000 claims description 10
- 239000004033 plastic Substances 0.000 claims description 10
- 230000013777 protein digestion Effects 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 230000004048 modification Effects 0.000 claims description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 7
- 230000029087 digestion Effects 0.000 claims description 6
- 238000011068 loading method Methods 0.000 claims description 6
- 229920000515 polycarbonate Polymers 0.000 claims description 6
- 239000004417 polycarbonate Substances 0.000 claims description 6
- 238000005070 sampling Methods 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- -1 polyethylene terephthalate Polymers 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 4
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 4
- 210000000601 blood cell Anatomy 0.000 claims description 4
- 239000012894 fetal calf serum Substances 0.000 claims description 4
- 244000045947 parasite Species 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- 230000009145 protein modification Effects 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 230000004075 alteration Effects 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- 210000002308 embryonic cell Anatomy 0.000 claims description 3
- 210000003743 erythrocyte Anatomy 0.000 claims description 3
- 238000009595 pap smear Methods 0.000 claims description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 3
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 3
- 229920000379 polypropylene carbonate Polymers 0.000 claims description 3
- 230000003612 virological effect Effects 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 11
- 239000000523 sample Substances 0.000 description 82
- 239000001993 wax Substances 0.000 description 82
- 238000003752 polymerase chain reaction Methods 0.000 description 23
- 108020004414 DNA Proteins 0.000 description 15
- 239000000047 product Substances 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 238000001514 detection method Methods 0.000 description 10
- 239000003921 oil Substances 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 239000012472 biological sample Substances 0.000 description 8
- 238000011109 contamination Methods 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000007834 ligase chain reaction Methods 0.000 description 7
- 108010067770 Endopeptidase K Proteins 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000013615 primer Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000001327 Förster resonance energy transfer Methods 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 210000004090 human X chromosome Anatomy 0.000 description 2
- 210000001182 human Y chromosome Anatomy 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- ZYURHZPYMFLWSH-UHFFFAOYSA-N octacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC ZYURHZPYMFLWSH-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 239000004429 Calibre Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000013382 DNA quantification Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 229920004142 LEXAN™ Polymers 0.000 description 1
- 239000004418 Lexan Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000004425 Makrolon Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 108010066717 Q beta Replicase Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- SMLXTTLNOGQHHB-UHFFFAOYSA-N [3-docosanoyloxy-2,2-bis(docosanoyloxymethyl)propyl] docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC SMLXTTLNOGQHHB-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004374 forensic analysis Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 230000001293 nucleolytic effect Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000012169 petroleum derived wax Substances 0.000 description 1
- 235000019381 petroleum wax Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/02—Burettes; Pipettes
- B01L3/021—Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids
- B01L3/0217—Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids of the plunger pump type
- B01L3/022—Capillary pipettes, i.e. having very small bore
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5082—Test tubes per se
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0832—Geometry, shape and general structure cylindrical, tube shaped
- B01L2300/0838—Capillaries
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0478—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure pistons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ2039A AUPQ203999A0 (en) | 1999-08-05 | 1999-08-05 | Sample tube |
| AUPQ7039A AUPQ703900A0 (en) | 2000-04-20 | 2000-04-20 | Reaction chamber and methods |
| PCT/AU2000/000931 WO2001011336A1 (en) | 1999-08-05 | 2000-08-04 | Direct aspiration-reaction and injection device and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ517565A true NZ517565A (en) | 2002-08-28 |
Family
ID=25646114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ517565A NZ517565A (en) | 1999-08-05 | 2000-08-04 | Direct aspiration-reaction and injection device and methods of use |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1218718A4 (enExample) |
| JP (1) | JP2003506708A (enExample) |
| CN (1) | CN1399716A (enExample) |
| CA (1) | CA2419714A1 (enExample) |
| NZ (1) | NZ517565A (enExample) |
| WO (1) | WO2001011336A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4992524B2 (ja) * | 2007-04-13 | 2012-08-08 | 株式会社島津製作所 | 反応容器プレート及び反応処理方法 |
| GB0715171D0 (en) * | 2007-08-03 | 2007-09-12 | Enigma Diagnostics Ltd | Sample processor |
| GB2500658A (en) * | 2012-03-28 | 2013-10-02 | Dna Electronics Ltd | Biosensor device and system |
| WO2014012100A1 (en) * | 2012-07-13 | 2014-01-16 | Constitution Medical, Inc. | Controlled dispensing of samples onto substrates |
| CN110575781B (zh) | 2014-06-18 | 2022-07-29 | 卢米耐克斯公司 | 用于磁混合的设备和方法 |
| CN106475164B (zh) * | 2016-10-24 | 2019-01-11 | 深圳市孔雀生物科技有限公司 | 一种组合式离心装置 |
| DE202020004407U1 (de) * | 2020-10-20 | 2020-11-24 | Friz Biochem Gmbh | Funktionalisierte Mikrotiterplatte, Reaktionslösung, und Kit zur Herstellung einer Reaktionslösung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2211098A1 (de) * | 1972-03-08 | 1973-09-13 | Guenther Kreft | Erweiterter saugzylinder mit huelse zum ansaugen von fluessigkeiten in pipetten |
| SE400703B (sv) * | 1973-05-23 | 1978-04-10 | Weller Hannelore | Medicinsk apparat for metning av blodsenkan |
| CA1113275A (en) * | 1978-09-22 | 1981-12-01 | John D. Mull | Method of introducing a liquid into a measuring tube |
| IL66551A (en) * | 1982-08-15 | 1985-11-29 | Cais Michael | Method for moving-bed chromatography and device therefor |
| DE3343887A1 (de) * | 1983-12-05 | 1985-06-13 | Walter Sarstedt Kunststoff-Spritzgußwerk, 5223 Nümbrecht | Anordnung zur plazierung eines trenngels zwischen zwei in einem probenroehrchen befindlichen phasen |
| US4804050A (en) * | 1987-04-30 | 1989-02-14 | K-V Associates, Inc. | Method of underground fluid sampling |
| US5968729A (en) * | 1994-06-10 | 1999-10-19 | Kosak; Kenneth M. | Use of centrifugation to prepare a retractable seal over reagents in a reaction container |
-
2000
- 2000-08-04 CN CN 00813877 patent/CN1399716A/zh active Pending
- 2000-08-04 WO PCT/AU2000/000931 patent/WO2001011336A1/en not_active Ceased
- 2000-08-04 CA CA002419714A patent/CA2419714A1/en not_active Abandoned
- 2000-08-04 NZ NZ517565A patent/NZ517565A/en unknown
- 2000-08-04 JP JP2001515943A patent/JP2003506708A/ja active Pending
- 2000-08-04 EP EP00949003A patent/EP1218718A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2419714A1 (en) | 2001-02-15 |
| CN1399716A (zh) | 2003-02-26 |
| WO2001011336A1 (en) | 2001-02-15 |
| JP2003506708A (ja) | 2003-02-18 |
| EP1218718A1 (en) | 2002-07-03 |
| EP1218718A4 (en) | 2003-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5804148B2 (ja) | 管内で対象成分を操作するための操作管 | |
| AU2008285458B2 (en) | Sample processor | |
| JP5766284B2 (ja) | 方法および装置 | |
| KR20070122195A (ko) | 다단계 반응을 수행하는 방법, 시약을 보관하기 위한부서지기 쉬운 용기, 및 정전기적으로 하전된 완드를이용하여 고체 시약을 전달하는 방법 | |
| JPWO2005012518A1 (ja) | 核酸検出用キット | |
| JP5444632B2 (ja) | 核酸増幅方法およびそれに用いる容器 | |
| AU2017268244B2 (en) | Filtration column assembly for diagnostic assay system | |
| CN114364811A (zh) | 具有pcr芯片的样品制备设备和多孔板 | |
| US20180214879A1 (en) | Nucleic acid amplification | |
| AU2022339971A1 (en) | Method of piercing seal for sample testing | |
| AU660615B2 (en) | Method and means to perform biochemical reactions | |
| JP7305988B2 (ja) | 粒子操作用デバイス | |
| NZ517565A (en) | Direct aspiration-reaction and injection device and methods of use | |
| JP5600880B2 (ja) | 改良された増幅試薬 | |
| US5273907A (en) | Method and means for perform biochemical reactions | |
| AU777999B2 (en) | Direct aspiration-reaction and injection device and methods of use | |
| AU2022270084B2 (en) | Systems, methods, and apparatus for automated self-contained biological analysis | |
| EP1026241B1 (en) | An improved method for preparing DNA from serum and plasma | |
| CN101147070A (zh) | 反应方法 | |
| JP4286926B2 (ja) | 反応容器 | |
| US20250389715A1 (en) | Point-of-care bioassay systems and methods of making and using the same | |
| JP4751720B2 (ja) | 遺伝子解析装置 | |
| WO2006106868A1 (ja) | 反応容器における不揮発性液体分注方法及び反応容器処理装置 | |
| Uchenna et al. | Comparison of Molecular and Conventional Methods of Detecting Cryptosporidium Parvum in Seropositive HIV Patient’s Fecal Specimens | |
| WO2026006318A1 (en) | Point-of-care bioassay systems and methods of making and using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: APS DIAGNOSTICS PTY LTD, AU Free format text: OLD OWNER(S): BRUCE HARRISON TRADING AS SXY TECH; BRIAN WILLIAM KING |
|
| S38A | Application for proceedings under section 38 (amendment of specification with leave of commissioner) |
Free format text: BY WAY OF DISCLAIMER |
|
| S38C | Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended |